TriSalus Life Sciences (TLSI) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts TLSI Hot Sheet
Join SI Premium – FREE
TriSalus Life Sciences (NASDAQ: TLSI) reported Q1 EPS of $0.03. Revenue for the quarter came in at $8.9 million.
For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- People Incorporated (PPLI) PT Lowered to $47 at Citizens - Shares Meaningfully Undervalue Business
- Hagerty Inc. (HGTY) PT Raised to $19 at Citizens on Durable Growth, Expanding Margins
- First Acceptance (FACO) Tops Q3 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
